Literature DB >> 25005439

Amyloid burden, neuroinflammation, and links to cognitive decline after ischemic stroke.

Alexander Thiel1, David F Cechetto1, Wolf-Dieter Heiss1, Vladimir Hachinski1, Shawn N Whitehead2.   

Abstract

Entities:  

Keywords:  amyloid; inflammation; stroke

Mesh：

Substances：

Year:  2014        PMID： 25005439     DOI： 10.1161/STROKEAHA.114.004285

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  40 in total

1.  EphrinB2 activation enhances angiogenesis, reduces amyloid-β deposits and secondary damage in thalamus at the early stage after cortical infarction in hypertensive rats.

Authors:  Shihui Xing; Nannan Pan; Wei Xu; Jian Zhang; Jingjing Li; Chao Dang; Gang Liu; Zhong Pei; Jinsheng Zeng
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-06       Impact factor: 6.200

2.  Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis?

Authors:  Ling-Chun Huang; Yu-Han Chang; Yuan-Han Yang
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

3.  Intracranial stenosis in cognitive impairment and dementia.

Authors:  Saima Hilal; Xin Xu; M Kamran Ikram; Henri Vrooman; Narayanaswamy Venketasubramanian; Christopher Chen
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 4.  Post-stroke remodeling processes in animal models and humans.

Authors:  Carla Cirillo; Nabila Brihmat; Evelyne Castel-Lacanal; Alice Le Friec; Marianne Barbieux-Guillot; Nicolas Raposo; Jérémie Pariente; Alain Viguier; Marion Simonetta-Moreau; Jean-François Albucher; Jean-Marc Olivot; Franck Desmoulin; Philippe Marque; François Chollet; Isabelle Loubinoux
Journal:  J Cereb Blood Flow Metab       Date:  2019-10-23       Impact factor: 6.200

5.  CD36 deficiency reduces chronic BBB dysfunction and scar formation and improves activity, hedonic and memory deficits in ischemic stroke.

Authors:  Mustafa Balkaya; Il-Doo Kim; Faariah Shakil; Sunghee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-13       Impact factor: 6.200

6.  Milder Alzheimer's disease pathology in heart failure and atrial fibrillation.

Authors:  Luciano A Sposato; Estefanía Ruíz Vargas; Patricia M Riccio; Jon B Toledo; John Q Trojanowski; Walter A Kukull; Lauren E Cipriano; Antonia Nucera; Shawn N Whitehead; Vladimir Hachinski
Journal:  Alzheimers Dement       Date:  2017-02-05       Impact factor: 21.566

Review 7.  Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.

Authors:  Sebastian A Lewandowski; Linda Fredriksson; Daniel A Lawrence; Ulf Eriksson
Journal:  Pharmacol Ther       Date:  2016-08-12       Impact factor: 12.310

8.  Assessing neuronal density in peri-infarct cortex with PET: Effects of cortical topology and partial volume correction.

Authors:  Thomas Funck; Mohammed Al-Kuwaiti; Claude Lepage; Peter Zepper; Jeffrey Minuk; Hyman M Schipper; Alan C Evans; Alexander Thiel
Journal:  Hum Brain Mapp       Date:  2016-09-10       Impact factor: 5.038

9.  Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine.

Authors:  Sigal Liraz-Zaltsman; Rami Yaka; Dalia Shabashov; Esther Shohami; Anat Biegon
Journal:  J Mol Neurosci       Date:  2016-07-16       Impact factor: 3.444

10.  Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment.

Authors:  Sung-Chun Tang; Kai-Chien Yang; Chih-Hao Chen; Shieh-Yueh Yang; Ming-Jang Chiu; Chau-Chung Wu; Jiann-Shing Jeng
Journal:  Neuromolecular Med       Date:  2018-09-21       Impact factor: 3.843
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.